Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 12, 2013

Bayer, Gentium, GlaxoSmithKline, Paladin, PsiOxus, Shield Therapeutics, The Medicines Co.

Phase I
Gentium DF test successful . . . read more

Phase II
PsiOxus gets good results against cachexia . . . read more

Phase III
GSK plaque-buster misses endpoint . . . read more

Shield files to begin CKD trial . . . read more

Filings
Bayer receives Eylea approval in Canada . . . read more

Paladin review date extended . . . read more

TMC’s ABSSSI NDA gets QIDP . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters